Compare INMB & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMB | MKTW |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 54.6M |
| IPO Year | 2018 | 2020 |
| Metric | INMB | MKTW |
|---|---|---|
| Price | $2.44 | $18.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $5.40 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 339.7K | 9.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 10.20% |
| EPS Growth | 11.85 | ★ 1183.33 |
| EPS | ★ N/A | N/A |
| Revenue | $50,000.00 | ★ $512,403,000.00 |
| Revenue This Year | N/A | $1.52 |
| Revenue Next Year | N/A | $4.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $13.49 |
| 52 Week High | $2.50 | $22.83 |
| Indicator | INMB | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 43.06 |
| Support Level | $1.16 | $16.16 |
| Resistance Level | $2.50 | $21.40 |
| Average True Range (ATR) | 0.12 | 0.54 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 52.51 | 23.21 |
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms, including mobile, desktop, and tablets.